# Yilu Lin

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/yilu-lin/

## Facts

| Field | Value |
| --- | --- |
| Citations | 219 |
| Field | Diabetes Treatment and Management |
| h-index | 9 |
| i10-index | 8 |
| Last Known Institution | Tulane University |
| OpenAlex ID | https://openalex.org/A5076229664 |
| ORCID iD | 0000-0001-7040-4287 |
| Works | 35 |

## Researcher papers

- [Analysis on geographic variations in hospital deaths and endovascular therapy in ischaemic stroke patients: an observational cross-sectional study in China](https://scholariq.org/papers/analysis-on-geographic-variations-in-hospital-deaths-and-endovascular-therapy-in/)
- [Using modern risk engines and machine learning/artificial intelligence to predict diabetes complications: A focus on the BRAVO model](https://scholariq.org/papers/using-modern-risk-engines-and-machine-learning-artificial-intelligence-to/)
- [Effects of medicaid expansion on poverty disparities in health insurance coverage](https://scholariq.org/papers/effects-of-medicaid-expansion-on-poverty-disparities-in-health-insurance/)
- [Predicting incident heart failure among patients with type 2 diabetes mellitus: The <scp>DM‐CURE</scp> risk score](https://scholariq.org/papers/predicting-incident-heart-failure-among-patients-with-type-2-diabetes-mellitus/)
- [The Effect of Proton Pump Inhibitor Use on the Course of Kidney Function in Patients with Chronic Kidney Disease Stages G3a to G4](https://scholariq.org/papers/the-effect-of-proton-pump-inhibitor-use-on-the-course-of-kidney-function-in/)
- [Exacerbation of financial burden of insulin and overall glucose‐lowing medications among uninsured population with diabetes](https://scholariq.org/papers/exacerbation-of-financial-burden-of-insulin-and-overall-glucose-lowing/)
- [Second-line rituximab–bendamustine versus rituximab–gemcitabine–oxaliplatin in diffuse large B-cell lymphoma in the real world](https://scholariq.org/papers/second-line-rituximab-bendamustine-versus-rituximab-gemcitabine-oxaliplatin-in/)
- [Optimizing treatment goals for long-term health outcomes among patients with type 2 diabetes mellitus](https://scholariq.org/papers/optimizing-treatment-goals-for-long-term-health-outcomes-among-patients-with/)
- [A machine learning approach identifies modulators of heart failure hospitalization prevention among patients with type 2 diabetes: A revisit to the ACCORD trial](https://scholariq.org/papers/a-machine-learning-approach-identifies-modulators-of-heart-failure/)
- [Emerging racial disparities among Medicare beneficiaries and Veterans with metastatic castration-sensitive prostate cancer](https://scholariq.org/papers/emerging-racial-disparities-among-medicare-beneficiaries-and-veterans-with/)
- [Epidemiology and burden of focal segmental glomerulosclerosis among United States Veterans: An analysis of Veteran’s Affairs data](https://scholariq.org/papers/epidemiology-and-burden-of-focal-segmental-glomerulosclerosis-among-united/)

## Researcher topics

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)
- [Chronic Lymphocytic Leukemia Research](https://scholariq.org/topics/chronic-lymphocytic-leukemia-research/)
- [Diabetes, Cardiovascular Risks, and Lipoproteins](https://scholariq.org/topics/diabetes-cardiovascular-risks-and-lipoproteins/)
- [Healthcare Policy and Management](https://scholariq.org/topics/healthcare-policy-and-management/)
- [Chronic Kidney Disease and Diabetes](https://scholariq.org/topics/chronic-kidney-disease-and-diabetes/)

## Researcher university

- [Tulane University](https://scholariq.org/institutions/tulane-university/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.